Compare SMBC & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMBC | FLGT |
|---|---|---|
| Founded | 1887 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 613.1M | 697.3M |
| IPO Year | N/A | 2016 |
| Metric | SMBC | FLGT |
|---|---|---|
| Price | $57.94 | $27.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $63.63 | $28.33 |
| AVG Volume (30 Days) | 52.5K | ★ 391.7K |
| Earning Date | 01-26-2026 | 11-07-2025 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | ★ 25.22 | N/A |
| EPS | ★ 5.46 | N/A |
| Revenue | $178,892,000.00 | ★ $315,549,000.00 |
| Revenue This Year | $17.66 | $16.84 |
| Revenue Next Year | $4.13 | $9.74 |
| P/E Ratio | $10.61 | ★ N/A |
| Revenue Growth | 10.39 | ★ 13.61 |
| 52 Week Low | $45.10 | $14.57 |
| 52 Week High | $66.81 | $31.04 |
| Indicator | SMBC | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 52.00 |
| Support Level | $55.91 | $27.52 |
| Resistance Level | $59.06 | $31.04 |
| Average True Range (ATR) | 1.19 | 0.92 |
| MACD | 0.31 | -0.38 |
| Stochastic Oscillator | 80.60 | 7.67 |
Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.